Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dancey

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Current Oncology (Toronto, Ont.)|July 17, 2020
Barriers to conducting cancer trials in Canada: an analysis of key informant interviewsC Bentley, S Sundquist, J Dancey, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 21, 2000
Effect of carbohydrate or carbohydrate plus medium-chain triglyceride ingestion on cycling time trial performanceD J Angus, M Hargreaves, J Dancey, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1996
Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials GroupD Osoba, J Dancey, B Zee, et al.
Seminars in Oncology|October 26, 2000
Novel therapeutic agents for the treatment of myelodysplastic syndromesB D Cheson, J A Zwiebel, J Dancey, et al.
British Journal of Cancer|July 27, 2013
Reporting practices of pharmacodynamic studies involving invasive research procedures in cancer trialsG A Freeman, J Kimmelman, J Dancey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Application of a new multinomial phase II stopping rule using response and early progressionS Dent, B Zee, J Dancey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponadeG Liu, M Crump, P E Goss, et al.
Bone Marrow Transplantation|September 11, 1998
The psychosocial impact of bone marrow transplantation: a review of the literatureC S Neitzert, P Ritvo, J Dancey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials GroupJ J Rusthoven, E Eisenhauer, C Butts, et al.
Investigational New Drugs|March 11, 2006
A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trialM Knowling, M Blackstein, R Tozer, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Current Oncology (Toronto, Ont.)|July 17, 2020
Barriers to conducting cancer trials in Canada: an analysis of key informant interviewsC Bentley, S Sundquist, J Dancey, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 21, 2000
Effect of carbohydrate or carbohydrate plus medium-chain triglyceride ingestion on cycling time trial performanceD J Angus, M Hargreaves, J Dancey, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1996
Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials GroupD Osoba, J Dancey, B Zee, et al.
Seminars in Oncology|October 26, 2000
Novel therapeutic agents for the treatment of myelodysplastic syndromesB D Cheson, J A Zwiebel, J Dancey, et al.
British Journal of Cancer|July 27, 2013
Reporting practices of pharmacodynamic studies involving invasive research procedures in cancer trialsG A Freeman, J Kimmelman, J Dancey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Application of a new multinomial phase II stopping rule using response and early progressionS Dent, B Zee, J Dancey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponadeG Liu, M Crump, P E Goss, et al.
Bone Marrow Transplantation|September 11, 1998
The psychosocial impact of bone marrow transplantation: a review of the literatureC S Neitzert, P Ritvo, J Dancey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials GroupJ J Rusthoven, E Eisenhauer, C Butts, et al.
Investigational New Drugs|March 11, 2006
A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trialM Knowling, M Blackstein, R Tozer, et al.
Pageof 4